Cardiovascular Innovations and Applications最新文献_第9页

A Rare Case of a Primary Cardiac Tumor Presenting as Fatal Ventricular Tachycardia 原发性心脏肿瘤致死性室性心动过速一例

IF 0.5 4区医学

Cardiovascular Innovations and Applications Pub Date : 2022-01-01 DOI: 10.15212/cvia.2022.0014

Xu-Dong Guo

引用次数: 0

The Neutrophil/Lymphocyte Ratio is Associated with Different Stages of Development of Coronary Artery Disease 中性粒细胞/淋巴细胞比值与冠状动脉疾病发展的不同阶段相关

IF 0.5 4区医学

Cardiovascular Innovations and Applications Pub Date : 2022-01-01 DOI: 10.15212/cvia.2022.0018

Jianlin Du

{"title":"The Neutrophil/Lymphocyte Ratio is Associated with Different Stages of Development of Coronary Artery Disease","authors":"Jianlin Du","doi":"10.15212/cvia.2022.0018","DOIUrl":"https://doi.org/10.15212/cvia.2022.0018","url":null,"abstract":"Introduction: Inflammation plays a role in coronary artery disease (CAD). The neutrophil/lymphocyte ratio (NLR),monocyte/lymphocyte ratio (MLR) and platelet/lymphocyte ratio (PLR) are blood parameters associated with inflammation.We aimed to perform a systematic comparison and study the predictive values of these inflammatory parameterswith respect to CAD stage.Method: A total of 513 patients who had undergone coronary angiography (CAG) were retrospectively analyzed.Clinical status, lipid profiles, CAG scans and hematological parameters were collected. NLR, MLR and PLR were calculated. All patients were classified into a normal coronary group (n = 133), coronary atherosclerosis (CA) group (n = 149), chronic coronary syndrome (CCS) group (n = 175) or acute myocardial infarction (AMI) group (n = 56). NLR, MLR and PLR were compared among groups.Results: NLR and MLR were higher in the CCS and AMI groups. PLR was higher in the AMI group. The AMI grouphad higher NLR, PLR and MLR than the CCS group. Logistic regression analysis revealed that NLR (OR:1.227, 95%CI: 1.016–1.482. P < 0.05) had a strong significant correlation with CAD. Area under the ROC curve of NLR was 0.580(95% CI = 0.516–0.644) in predicting CCS and 0.727 (95% CI = 0.642–0.811) in predicting AMI.Conclusion: NLR may be associated with the occurrence and progression of CAD, and may serve as a marker of inflammation.","PeriodicalId":41559,"journal":{"name":"Cardiovascular Innovations and Applications","volume":"13 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67305858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 4

Dapagliflozin in Heart Failure with Reduced Ejection Fraction: A Real-World Study 达格列净治疗心力衰竭伴射血分数降低:一项现实世界研究

IF 0.5 4区医学

Cardiovascular Innovations and Applications Pub Date : 2022-01-01 DOI: 10.15212/cvia.2022.0005

Yanzhou Zhang

{"title":"Dapagliflozin in Heart Failure with Reduced Ejection Fraction: A Real-World Study","authors":"Yanzhou Zhang","doi":"10.15212/cvia.2022.0005","DOIUrl":"https://doi.org/10.15212/cvia.2022.0005","url":null,"abstract":"Aims: We aimed to observe the improvements in cardiac function indexes and the occurrence of adverse events in patients with heart failure with reduced ejection fraction (HFrEF) after dapagliflozin administration in a real-world setting.Methods: We retrospectively enrolled 201 patients with HFrEF who were treated at a tertiary hospital in Zhengzhou and started to take dapagliflozin (10 mg/d) from March 2020 to June 2021. Their New York Heart Association (NYHA) functional class, cardiac ultrasound indexes, laboratory indexes, and vital signs between baseline and the last follow-up visit were compared, and their adverse events during the follow-up period were recorded.Results: The follow-up period was 173 (67–210) days. The cardiac function indexes of patients at follow-up, compared with baseline, indicated significant improvement (proportion of NYHA functional class I and II: 40.8% vs. 56.2%; left ventricular ejection fraction: 28.4 ± 5.3% vs. 34.7 ± 5.9%; left ventricular end-diastolic diameter: 70.1 ± 6.4 mm vs. 64.7 ± 5.6 mm; N-terminal pro-B-type natriuretic peptide: 5421.9 ± 2864.4 pg/mL vs. 2842.8 ± 1703.4 pg/mL at baseline vs. at follow-up; all P < 0.05). The rates of hypotension, deterioration of renal function, and genital infection during the follow-up period were 6.5%, 4.0%, and 3.5%, respectively.Conclusions: We believe that dapagliflozin is safe and effective in patients with HFrEF in the real world.","PeriodicalId":41559,"journal":{"name":"Cardiovascular Innovations and Applications","volume":"1 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67304968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

A Novel Robotic Control System Mimics Doctor’s Operation to Assist Percutaneous Coronary Intervention 一种新型机器人控制系统模拟医生手术以辅助经皮冠状动脉介入治疗

IF 0.5 4区医学

Cardiovascular Innovations and Applications Pub Date : 2022-01-01 DOI: 10.15212/cvia.2022.0003

Ping Zhang

{"title":"A Novel Robotic Control System Mimics Doctor’s Operation to Assist Percutaneous Coronary Intervention","authors":"Ping Zhang","doi":"10.15212/cvia.2022.0003","DOIUrl":"https://doi.org/10.15212/cvia.2022.0003","url":null,"abstract":"Objectives: The use of current robotic systems to assist in percutaneous coronary intervention (PCI) fundamentallydiffers from performing conventional PCI. To overcome this problem, we developed a novel master-slave roboticcontrol system to assist in PCI, and evaluated its safety and feasibility in the delivery and manipulation of coronaryguidewires in vitro and in vivo.Methods: The novel robotic assist PCI system is composed of three parts: 1) a master actuator, which imitates thetraditional torque used by surgeons in conventional PCI, 2) a slave actuator, including a guidewire delivery system andforce monitoring equipment, and 3) a local area network based communication system.Results: The experiment was performed in six pigs. Both robotic and manual control completed the operation with no device- or procedure-associated complications. An experienced interventional cardiologist who was a first-time userof the novel robotic PCI system was able to advance the guidewire into a distal branch of a coronary artery within asimilar time to that required with the manual procedure.Conclusion: This early in vivo experiment with the novel robotic assisted PCI control system demonstrated that its feasibility, safety, and procedural effectiveness are comparable to those of manual operation. The novel robotic-assisted PCI control system required significantly less time to learn than other currently available systems.","PeriodicalId":41559,"journal":{"name":"Cardiovascular Innovations and Applications","volume":"93 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67305341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Hypertensive-Like Reaction: A Definition for Normotensive Individuals with Symptoms Associated with Elevated Blood Pressure 高血压样反应:血压升高相关症状的正常个体的定义

IF 0.5 4区医学

Cardiovascular Innovations and Applications Pub Date : 2022-01-01 DOI: 10.15212/cvia.2022.0004

Yifang Guo

引用次数: 0

Application Potential of Probiotics in Acute Myocardial Infarction 益生菌在急性心肌梗死中的应用潜力

IF 0.5 4区医学

Cardiovascular Innovations and Applications Pub Date : 2022-01-01 DOI: 10.15212/cvia.2022.0019

Hui Jiang

引用次数: 2

Role of Epicardial Adipose Tissue in Triggering and Maintaining Atrial Fibrillation 心外膜脂肪组织在诱发和维持心房颤动中的作用

IF 0.5 4区医学

Cardiovascular Innovations and Applications Pub Date : 2022-01-01 DOI: 10.15212/cvia.2022.0012

Ye Tian

引用次数: 3

Mechanisms of Myocardial Stunning in Stress-Induced Cardiomyopathy* 应激性心肌病心肌休克机制*

IF 0.5 4区医学

Cardiovascular Innovations and Applications Pub Date : 2022-01-01 DOI: 10.15212/cvia.2022.0010

Dechun Yin

引用次数: 1

The Role of Sleep Deprivation in Arrhythmias 睡眠剥夺在心律失常中的作用

IF 0.5 4区医学

Cardiovascular Innovations and Applications Pub Date : 2022-01-01 DOI: 10.15212/cvia.2022.0013

Dechun Yin

引用次数: 0

Effects of Loading-Dose Statins Combined with PCSK9 Inhibitor Pre-Treatment before Primary Percutaneous Coronary Intervention on the Short-Term Prognosis in Patients with ST-Segment Elevation Myocardial Infarction 初次经皮冠状动脉介入治疗前负荷剂量他汀类药物联合PCSK9抑制剂对st段抬高型心肌梗死患者短期预后的影响

IF 0.5 4区医学

Cardiovascular Innovations and Applications Pub Date : 2022-01-01 DOI: 10.15212/cvia.2022.0011

J. An

{"title":"Effects of Loading-Dose Statins Combined with PCSK9 Inhibitor Pre-Treatment before Primary Percutaneous Coronary Intervention on the Short-Term Prognosis in Patients with ST-Segment Elevation Myocardial Infarction","authors":"J. An","doi":"10.15212/cvia.2022.0011","DOIUrl":"https://doi.org/10.15212/cvia.2022.0011","url":null,"abstract":"Objective: This study was aimed at investigating the effects of preoperative treatment with a loading dose of statinscombined with a PCSK9 inhibitor on coronary blood perfusion and short-term cardiovascular adverse events in patientswith ST-segment elevation myocardial infarction (STEMI).Method: Sixty-five patients with STEMI who had visited the Shanxi Cardiovascular Disease Hospital between May2018 and May 2021 were enrolled in the study. The enrolled patients had no history of oral statins or antiplatelet therapy.The patients were divided into a combined treatment group (loading dose of statins combined with PCSK9 inhibitors, 35patients) and a routine treatment group (loading dose of statins only, 30 patients). The primary endpoints were thrombolysisin myocardial infarction (TIMI) blood flow grading, corrected TIMI frame count (CTFC), and TIMI myocardial perfusiongrading (TMPG), immediately after and 30 days after the operation. The secondary endpoint was a composite endpoint ofcardiovascular death, nonfatal myocardial infarction, and target vessel revascularization 30 days after the operation.Results: The combined treatment group had significantly lower CTFC (14.09 ± 8.42 vs 26 ± 12.42, P = 0.04) and betterTMPG (2.74 ± 0.61 vs 2.5 ± 0.73, P = 0.04) than the routine treatment group immediately after the operation. Similarly,the combined treatment group had a significantly lower CTFC (16.29 ± 7.39 vs 26.23 ± 11.53, P = 0.04) and significantlybetter TMPG (2.94 ± 0.24 vs 2.76 ± 0.43, P = 0.01) than the routine treatment group 1 month after the operation.Conclusion: Preoperative treatment with a loading dose of high-intensity statins combined with PCSK9 inhibitorsincreased coronary blood flow and myocardial perfusion after emergency thrombus aspiration in patients withSTEMI. However, the treatment did not significantly decrease the incidence of cardiovascular death, nonfatal myocardialinfarction, or target vessel revascularization.","PeriodicalId":41559,"journal":{"name":"Cardiovascular Innovations and Applications","volume":"1 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67305590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3